Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells
Bioscience Reports · 2024
DOI: 10.1042/bsr20240182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, 2024. Verfasst von Laiyen Garcia Delgado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology. Hauptthemen laut MEDLINE: Sorting Nexins, Proto-Oncogene Proteins c-met, Colorectal Neoplasms, Hepatocyte Growth Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Cumulative research findings support the idea that endocytic trafficking is crucial in regulating receptor signaling and associated diseases. Specifically, strong evidence points to the involvement of sorting nexins (SNXs), particularly SNX1 and SNX2, in the signaling and trafficking of the receptor tyrosine kinase (RTK) MET in colorectal cancer (CRC). Activation of hepatocyte growth factor (HGF) receptor MET is a key driver of CRC progression. In the present study, we utilized human HCT116 CRC cells with SNX1 and SNX2 genes knocked out to demonstrate that their absence leads to a delay in MET entering early endosomes. This delay results in increased phosphorylation of both MET and AKT upon HGF stimulation, while ERK1/2 (extracellular signal-regulated kinases 1 and 2) phosphorylation remains unaffected. Despite these changes, HGF-induced cell proliferation, scattering, and migration remain similar between the parental and the SNX1/2 knockout cells. However, in the absence of SNX1 and SNX2, these cells exhibit increased resistance to TRAIL-induced apoptosis. This research underscores the intricate relationship between intracellular trafficking, receptor signaling, and cellular responses and demonstrates for the first time that the modulation of MET trafficking by SNX1 and SNX2 is critical for receptor signaling that may exacerbate the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology.
- Pharmacology Institute of Sherbrooke (IPS).
- Université de Sherbrooke's Cancer Research Institute (IRCUS), Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.
- Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences.
- Centre de Recherche Clinique CHUS.
ORCID-Profile: Jean-Bernard Denault
Förderung
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Garcia Delgado, L., Derome, A., Longpré, S., Giroux-Dansereau, M., Basbous, G., Lavoie, C., Saucier, C., & Denault, J. B. (2024). Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells. Bioscience Reports. https://doi.org/10.1042/bsr20240182
Vancouver
Garcia Delgado L, Derome A, Longpré S, Giroux-Dansereau M, Basbous G, Lavoie C, et al. Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells. Bioscience Reports. 2024. doi:10.1042/bsr20240182
BibTeX
@article{GarciaDelgado2024,
author = {Garcia Delgado, Laiyen and Derome, Amélie and Longpré, Samantha and Giroux-Dansereau, Marilyne and Basbous, Ghenwa and Lavoie, Christine and Saucier, Caroline and Denault, Jean-Bernard},
title = {Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells},
journal = {Bioscience Reports},
year = {2024},
doi = {10.1042/bsr20240182}
}
EUVIMED